Published in Am Rev Respir Dis on July 01, 1993
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Extracellular DNA in single- and multiple-species unsaturated biofilms. Appl Environ Microbiol (2005) 2.07
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax (1995) 1.67
Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 1.54
Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Pediatr Radiol (2005) 1.48
In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax (1996) 1.09
Engineering actin-resistant human DNase I for treatment of cystic fibrosis. Proc Natl Acad Sci U S A (1996) 1.09
Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence. Protein Sci (1998) 1.09
Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis. Thorax (1998) 1.09
Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes (2005) 1.02
Lung function from infancy to school age in cystic fibrosis. Arch Dis Child (1995) 0.94
Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. ScientificWorldJournal (2012) 0.92
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis. J Inflamm Res (2013) 0.91
rhDNase in cystic fibrosis. Thorax (1995) 0.87
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis. Biologics (2008) 0.86
Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data. Eur J Health Econ (2014) 0.84
Ca2+-dependent activity of human DNase I and its hyperactive variants. Protein Sci (1999) 0.83
Cystic fibrosis: an inherited disease affecting mucin-producing organs. Int J Biochem Cell Biol (2014) 0.81
The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems. Thorax (1996) 0.80
Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis. Thorax (1997) 0.78
Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis. Thorax (1997) 0.77
Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective? Arch Dis Child (1997) 0.77
Commuting mode and pulmonary function in Shanghai, China. Eur Respir J (2015) 0.76
Targeting of dornase alpha therapy in adult cystic fibrosis. J R Soc Med (1998) 0.75
Socioeconomic status is associated with reduced lung function in China: an analysis from a large cross-sectional study in Shanghai. BMC Public Health (2016) 0.75
Bacterial Biofilm Control by Perturbation of Bacterial Signaling Processes. Int J Mol Sci (2017) 0.75
Effects of the RAD52 Gene on Recombination in SACCHAROMYCES CEREVISIAE. Genetics (1980) 6.07
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Informed consent for population-based research involving genetics. JAMA (2001) 4.10
Something is (not) rotten in Denmark [Hamlet (not) W. Shakespeare]. Pediatr Pulmonol (1997) 3.51
Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med (1993) 3.27
Research ethics. Research practice and participant preferences: the growing gulf. Science (2011) 3.27
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet (1993) 3.17
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet (1999) 2.71
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol (1997) 2.65
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers. Chest (1990) 2.52
The complexities of predictive genetic testing. BMJ (2001) 2.36
Turning interns into senior residents: preparing residents for their teaching and leadership roles. Acad Med (1995) 2.31
Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun (1996) 2.25
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol (2001) 2.24
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr (1994) 2.10
Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet (2012) 2.07
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05
Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am J Respir Crit Care Med (2000) 1.94
Anatomy of the healthy worker effect: a critical review. J Occup Med (1983) 1.90
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr (1995) 1.75
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax (2004) 1.71
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest (1996) 1.70
A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol (2000) 1.68
Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther (2001) 1.58
Reproductive health in males with cystic fibrosis: knowledge, attitudes, and experiences of patients and parents. Pediatr Pulmonol (1998) 1.57
Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet (2000) 1.57
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56
What internists need to know: core competencies in women's health. ABIM Subcommittee on Clinical Competence in Women's Health. Am J Med (1997) 1.55
Effect of altering smooth muscle tone on maximal expiratory flows in patients with tracheomalacia. Pediatr Pulmonol (1990) 1.54
Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med (1987) 1.54
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol (2008) 1.53
Increase in desipramine serum levels associated with methadone treatment. Am J Psychiatry (1989) 1.53
Practice of pediatric pulmonology: results of the Future of Pediatric Education Project (FOPE) Pediatr Pulmonol (2000) 1.52
Arthritis in cystic fibrosis. Arch Dis Child (1984) 1.52
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. Pediatr Pulmonol (2000) 1.52
Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest (1993) 1.52
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev (1999) 1.49
Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol (1998) 1.46
Primary care internal medicine: a challenging career choice for the 1990s. Ann Intern Med (1990) 1.45
Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis (1993) 1.44
Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study. Pediatrics (2001) 1.44
Pulmonary function in hospitalized infants and toddlers with cystic fibrosis. J Pediatr (1998) 1.43
Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA (1992) 1.43
Practical approach to the diagnosis and treatment of apnea of infancy. Isr J Med Sci (1990) 1.41
Electrodiagnosis reliability in the diagnosis of infant botulism. J Pediatr (1992) 1.41
If you care about women's health, perhaps you should care about the risks of direct marketing of tamoxifen to consumers. Eff Clin Pract (2000) 1.39
Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax (2001) 1.37
The advent of the "unpatients'. Nat Med (1996) 1.36
Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines. Am J Physiol (1990) 1.35
Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J (2007) 1.34
Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis. Pediatr Res (1990) 1.33
Disuse in the lateral geniculate nucleus of the cat. J Physiol (1968) 1.33
Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients. J Pediatr (1986) 1.33
Long-term mortality study of oil refinery workers. I. Mortality of hourly and salaried workers. Am J Epidemiol (1983) 1.32
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer (2011) 1.31
Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol (1999) 1.29
The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series. Dev Med Child Neurol (1994) 1.29
Consensus conference: practical applications of Pulmozyme. September 22, 1993. Pediatr Pulmonol (1994) 1.28
Temporal order in yeast chromosome replication. Cell (1975) 1.25
Psoas abscess in chronic dialysis patients. J Urol (1987) 1.24
Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am J Respir Crit Care Med (1995) 1.23
Plasticity in adult cat visual cortex (area 17) following circumscribed monocular lesions of all retinal layers. J Physiol (2000) 1.18
Retrospective mortality and medical surveillance studies of workers in benzene areas of refineries. J Occup Med (1983) 1.18
Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J (2008) 1.16
Discharge patterns of principal cells and interneurones in lateral geniculate nucleus of rat. J Physiol (1966) 1.15
Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.15
Public health impact of genetic tests at the end of the 20th century. Genet Med (2001) 1.15
Challenges in communicating genetics: a public health approach. Genet Med (2001) 1.14
Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros (2009) 1.13
Reproductive and sexual health in males with cystic fibrosis: a case for health professional education and training. J Adolesc Health (2001) 1.12
Age of onset in Huntington's disease: lack of parental age effect. J Med Genet (1976) 1.12
Passive respiratory mechanics: the occlusion techniques. Eur Respir J (2001) 1.11
Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure. J Clin Epidemiol (1992) 1.09
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma. Br J Cancer (2012) 1.09
Actual tracheal oxygen concentrations with commonly used oxygen equipment. Anesthesiology (1976) 1.08
Uncertainties in genetic testing for chronic disease. JAMA (1998) 1.07
Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.07
Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest (1996) 1.07
Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis (1986) 1.06
Airway management for a neonate with congenital fusion of the jaws. Anesthesiology (1979) 1.06
Coronary artery perforations in the contemporary interventional era. J Interv Cardiol (2009) 1.06
Effect of heat delivery and extraction on airway conductance in normal and in asthmatic subjects. Am Rev Respir Dis (1985) 1.05
Immotile cilia syndrome. N Engl J Med (1983) 1.03
Airway area by acoustic reflections measured at the mouth. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.03
Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet (1992) 1.03
Ethical issues in developing pharmacogenetic research partnerships with American Indigenous communities. Clin Pharmacol Ther (2011) 1.02